Healthy Volunteer Study Comparing Tablet and Capsule Formulations

Inclusion Criteria: * Able to provide written informed consent * Agree to no smoking or alcohol or illegal substance 48 hours prior to dosing * Normal BMI (18 to ≤ 35 kg/m2) * Have a negative urine drug screen/alcohol breath test on admission to clinic * Agree to use highly effective, double barrier contraception (both male and female partners) during the study and for 90 days following completion of dosing * Females of childbearing potential must have a negative serum pregnancy test at Screening and a negative urine or serum pregnancy test on Day -1 * Be in general good health * Clinical laboratory values within normal range Exclusion Criteria: * Recent wound, or presence of an ongoing non-healing skin wound * Presence of any underlying physical or psychological medical condition that, in the opinion of the Investigator, would make it unlikely that the subject will complete the study per protocol * History or presence of alcoholism or drug abuse within the 2 years prior to the first study drug administration, and unwillingness to be totally abstinent during the dosing period * Blood donation or significant blood loss within 30 days prior to the first study drug administration * Plasma donation within 7 days prior to the first study drug administration * Administration of investigational product (IP) in another trial within 30 days prior to the first study drug administration, or five half-lives, whichever is longer * Females who are pregnant or lactating * Surgery within the past 3 months prior to the first study drug administration determined by the PI to be clinically relevant * Failure to satisfy the PI of fitness to participate for any other reason * Active infection or history of recurrent infections * Active malignancy and history of malignancy in the past 2 years, with the exception of completely excised basal cell carcinoma or low grade cervical intraepithelial neoplasia * Antibiotic treatment within 3 months * Chronic medical condition * Any acute illness within 30 days prior Other protocol defined inclusion/exclusion criteria could apply.